Review: taking Abilify and Invega sustenna together


Summary

Drug interactions are reported among people who take Abilify and Invega sustenna together. This review analyzes the effectiveness and drug interactions between Abilify and Invega sustenna. It is created by eHealthMe based on reports of 35 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Abilify and Invega sustenna >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Abilify

Abilify has active ingredients of aripiprazole. It is often used in bipolar disorder. (latest outcomes from Abilify 29,790 users)

Invega Sustenna

Invega sustenna has active ingredients of paliperidone palmitate. It is often used in schizophrenia. (latest outcomes from Invega sustenna 3,248 users)

On Jul, 20, 2016

35 people who take Abilify, Invega Sustenna are studied.


Number of reports submitted per year:

Abilify and Invega sustenna drug interactions.

Drug effectiveness over time:

Abilify:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Invega Sustenna:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Abilify:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)
Invega Sustenna:
  • female: 0.0% - (0 of 0 people)
  • male: 100.0% - (1 of 1 people)

Drug effectiveness by age:

Abilify:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Invega Sustenna:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)

Most common drug interactions over time *:

< 1 month:
  • major depression
  • psychomotor hyperactivity
  • aggression
  • disturbance in social behaviour
  • hostility
  • impulsive behaviour
  • agitation
  • anger
  • hallucination, auditory
  • hunger
1 - 2 years:
  • mood swings
10+ years:
  • mood swings
not specified:
  • agitation
  • anger
  • hunger
  • psychomotor hyperactivity
  • suicidal ideation
  • drug ineffective
  • injection site abscess
  • skin irritation
  • aggression
  • disturbance in social behaviour

Most common drug interactions by gender *:

female:
  • injection site abscess
  • skin irritation
  • drug ineffective
  • galactorrhoea
  • intentional self-injury
  • hyperprolactinaemia
  • extrapyramidal disorder
  • amenorrhoea
  • blood prolactin increased
  • suicide attempt
male:
  • agitation
  • anger
  • hunger
  • psychomotor hyperactivity
  • suicidal ideation
  • aggression
  • disturbance in social behaviour
  • hostility
  • impulsive behaviour
  • hallucination, auditory

Most common drug interactions by age *:

10-19:
  • feeling abnormal
  • gastrooesophageal reflux disease
  • hypothyroidism
  • infectious mononucleosis
  • psychotic disorder
  • ulcer
20-29:
  • completed suicide
  • intentional self-injury
  • blood prolactin increased
  • galactorrhoea
  • depression
  • hyperprolactinaemia
  • mental impairment
  • mood swings
  • psychotic behaviour
30-39:
  • drug ineffective
  • swollen tongue
  • galactorrhoea
  • mental disorder
  • abnormal behaviour
  • drug administration error
  • dyskinesia
  • dystonia
  • eye movement disorder
  • lip swelling
40-49:
  • injection site abscess
  • skin irritation
  • drug ineffective
  • lactation disorder
50-59:
  • agitation
  • anger
  • hunger
  • psychomotor hyperactivity
  • suicidal ideation
  • hallucination, auditory
  • major depression
  • suicide attempt
  • blood pressure increased
  • drug ineffective

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Abilify and Invega sustenna?

Can you answer these questions?

More questions for: Abilify, Invega sustenna

You may be interested in these reviews

More reviews for: Abilify, Invega sustenna

On eHealthMe, Abilify (aripiprazole) is often used to treat bipolar disorder. Invega sustenna (paliperidone palmitate) is often used to treat schizophrenia. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.